Marker molecules related to the prognosis of gastric cancer
A prognostic and gastric cancer technology, which can be used in the determination/examination of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., and can solve the problems of screening HubGenes and building risk prediction models.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0048] 1. Data acquisition
[0049] The gene expression profile data of gastric cancer (STAD) patient samples and control samples (32 cases) were obtained from the TCGA database, and the mutation information and survival information (DFS) of the patient samples were obtained from the cBioportal website (http: / / www.cbioportal.org / ). ), age information, pathological stage and other clinical information, and selected samples with clear survival information and pathological stage and expression values, a total of 267 cases.
[0050] The dataset numbered GSE62254 was downloaded from the GEO database (http: / / www.ncbi.nlm.nih.gov / geo / ), and the chip platform was GPL570, which contained gene expression profile data and survival information of 300 gastric cancer patient samples.
[0051] 31 m6A methylation regulators with different roles in the methylation process were obtained from the literature: Writers (methyltransferases)-METTL3, METTL14, METTL16, WTAP, VIRMA (KIAA1429), RBMX, ZC3...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


